[1]
S, S. and K, P. 2023. DRUG REPURPOSING OF COMMERCIALLY AVAILABLE AZOLES AGAINST ASPERGILLOSIS PEROXIREDOXIN ASP F3 ALLERGEN DRUGS. Innovare Journal of Medical Sciences. 11, 2 (Mar. 2023), 15–19. DOI:https://doi.org/10.22159/ijms.2023.v11i2.47142.